Neurocognitive Function of Patients with Brain Metastasis Who Received Either Whole Brain Radiotherapy Plus Stereotactic Radiosurgery or Radiosurgery Alone

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 5, 2007, Pages 1388-1395

  Aoyama, Hidefumi ^a   Tago, Masao ^b   Kato, Norio ^a   Toyoda, Tatsuya ^c   Kenjyo, Masahiro ^d   Hirota, Saeko ^e   Shioura, Hiroki ^f   Inomata, Taisuke ^g   Kunieda, Etsuo ^h   Hayakawa, Kazushige ⁱ   Nakagawa, Keiichi ^b   Kobashi, Gen ^a   Shirato, Hiroki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^c Kanto Teishin Hospital   (Japan)

^d HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^e HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^f Izumisano Municipal Hospital   (Japan)

^g OSAKA MEDICAL COLLEGE   (Japan)

^h KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Brain metastasis; Leukoencephalopathy; Neurocognitive function; Radiosurgery; Whole brain radiotherapy

Indexed keywords

BRAIN; PATIENT MONITORING; RADIATION EFFECTS; RADIOTHERAPY; TUMORS;

BRAIN METASTASIS; LEUKOENCEPHALOPATHY; NEUROCOGNITIVE FUNCTION; RADIOSURGERY; WHOLE BRAIN RADIOTHERAPY;

NEUROLOGY;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BRAIN TUMOR; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; COGNITION; EDEMA; FEMALE; FOLLOW UP; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOSURGERY; SCORING SYSTEM; SKIN FIBROSIS; STATISTICAL SIGNIFICANCE; STEREOTAXIC SURGERY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; COGNITION; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEMALE; HUMANS; JAPAN; KARNOFSKY PERFORMANCE STATUS; MAGNETIC RESONANCE IMAGING; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOSURGERY;

EID: 34547427370     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.03.048     Document Type: Article

References (25)

1. Aoyama H., Shirato H., Tago M., et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radiosurgery alone for treatment of brain metastases: A randomized controlled trial. JAMA 295 (2006) 2483-2491
2. Andrews D.W., Scott C.B., Sperduto P.W., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet 363 (2004) 1665-1672
3. Filley C.M., and Kleinschmidt-DeMasters B.K. Toxic leukoencephalopathy. N Engl J Med 345 (2001) 425-432
4. Hasegawa T., Kondziolka D., Flickinger J.C., et al. Brain metastases treated with radiosurgery alone: An alternative to whole brain radiotherapy?. Neurosurgery 52 (2003) 1318-1326
5. Yamamoto M., Ide M., Nishio S., et al. Gamma knife radiosurgery for numerous brain metastases: Is this a safe treatment?. Int J Radiat Oncol Biol Phys 53 (2002) 1279-1283
6. Sneed P.K., Suh J.H., Goetsch S.J., et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53 (2002) 519-526
7. Aoyama H., Shirato H., Onimaru R., et al. Hypofractionated stereotactic radiotherapy alone without whole brain irradiation for patients with solitary and oligo brain metastasis using non-invasive fixation of the skull. Int J Radiat Oncol Biol Phys 56 (2003) 793-800
8. Regine W.F., Scott C., Murray K., et al. Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: An analysis from Radiation Therapy Oncology Group Study 91-04. Int J Radiat Oncol Biol Phys 51 (2001) 711-717
9. Murray K.J., Scott C., Zachariah B., et al. Importance of the mini-mental status examination in the treatment of patients with brain metastases: A report from the Radiation Therapy Oncology Group protocol 91-04. Int J Radiat Oncol Biol Phys 48 (2000) 59-64
10. Brown P.D., Buckner J.C., O'Fallon J.R., et al. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the Folstein Mini-Mental State Examination. J Clin Oncol 21 (2003) 2519-2524
11. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
12. Crum R.M., Anthony J.C., Bassett S.S., et al. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 269 (1993) 2386-2391
13. Temkin N.R., Heaton R.K., Grant I., et al. Detecting significant change in neuropsychological test performance: A comparison of four models. J Int Neuropsychol Soc 5 (1999) 357-369
14. RTOG/EORTC late radiation morbidity scoring schema. Available at: http://www.rtog.org/members/toxicity/late.html. Accessed June 15, 1999.
15. Fujii O., Tsujino K., Soejima T., et al. White matter changes on magnetic resonance imaging following whole-brain radiotherapy for brain metastases. Radiat Med 24 (2006) 345-350
16. Auperin A., Arriagada R., Pignon J.P., et al., for the Prophylactic Cranial Irradiation Overview Collaborative Group. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 341 (1999) 476-484
17. van de Pol M., ten Velde G.P., Wilmink J.T., et al. Efficacy and safety of prophylactic cranial irradiation in patients with small cell lung cancer. J Neurooncol 35 (1997) 153-160
18. Stuschke M., Eberhardt W., Pottgen C., et al. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: Long-term follow-up and investigations of late neuropsychologic effects. J Clin Oncol 17 (1999) 2700-2709
19. Cull A., Gregor A., Hopwood P., et al. Neurological and cognitive impairment in long-term survivors of small cell lung cancer. Eur J Cancer 30 (1994) 1067-1074
20. Meyers C.A., and Wefel J.S. The use of the Mini-Mental State Examination to assess cognitive functioning in cancer trials: No ifs, ands, or buts, or sensitivity. J Clin Oncol 21 (2003) 3557-3558
21. Mehta M.P., Shapiro W.R., Glantz M.J., et al. Lead-in phase to randomized trial of motexafin gadolinium and whole brain radiation for patients with brain metastases: Centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points. J Clin Oncol 20 (2002) 3445-3453
22. Mehta M.P., Rodrigus P., Terhaard C.H., et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 21 (2003) 2529-2536
23. Meyers C.A., Smith J.A., Bezjak A., et al. Neurocognitive function and progression in patients with brain metastases treated with whole brain radiation and motexafin gadolinium: Results of a randomized phase III trial. J Clin Oncol 22 (2004) 157-165
24. Regine W.F., Schmitt F.A., Scott C.B., et al. Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: Results of Radiation Therapy Oncology Group trial BR-0018. Int J Radiat Oncol Biol Phys 58 (2004) 1346-1352
25. Shaw E.G., Rosdhal R., D'Agostino Jr. R.B., et al. Phase II study of donepezil in irradiated brain tumor patients: Effect on cognitive function, mood, and quality of life. J Clin Oncol 24 (2006) 1415-1420